Fertility Treatments Market Global Report 2020-30 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global fertility treatments market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the fertility treatments? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Fertility Treatments market global report from the author answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider fertility treatments market, and compares it with other markets.
Scope
Markets Covered: 1) By Product: Reagents; Equipment; 2) By End-User: Fertility Clinics; Hospitals; Surgical Centers; Clinical Research Institutes
Companies Mentioned: Apollo Hospitals Enterprise Ltd.; Care Fertility Group; Genea Limited; The Johns Hopkins Health System Corp; Medicover Group
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the fertility treatments? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Fertility Treatments market global report from the author answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider fertility treatments market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
- The fertility treatments market section of the report gives context. It compares the fertility treatments market with other segments of the fertility treatments market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, fertility treatments indicators comparison.
Scope
Markets Covered: 1) By Product: Reagents; Equipment; 2) By End-User: Fertility Clinics; Hospitals; Surgical Centers; Clinical Research Institutes
Companies Mentioned: Apollo Hospitals Enterprise Ltd.; Care Fertility Group; Genea Limited; The Johns Hopkins Health System Corp; Medicover Group
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary2. Fertility Treatments Market Characteristics26. Key Mergers And Acquisitions In The Fertility Treatments Market27. Fertility Treatments Market Trends And Strategies28. Fertility Treatments Market Future Outlook and Potential Analysis
3. Fertility Treatments Market Size And Growth
4. Fertility Treatments Market Segmentation
5. Fertility Treatments Market Regional And Country Analysis
6. Asia-Pacific Fertility Treatments Market
7. China Fertility Treatments Market
8. India Fertility Treatments Market
9. Japan Fertility Treatments Market
10. Australia Fertility Treatments Market
11. Indonesia Fertility Treatments Market
12. South Korea Fertility Treatments Market
13. Western Europe Fertility Treatments Market
14. UK Fertility Treatments Market
15. Germany Fertility Treatments Market
16. France Fertility Treatments Market
17. Eastern Europe Fertility Treatments Market
18. Russia Fertility Treatments Market
19. North America Fertility Treatments Market
20. USA Fertility Treatments Market
21. South America Fertility Treatments Market
22. Brazil Fertility Treatments Market
23. Middle East Fertility Treatments Market
24. Africa Fertility Treatments Market
25. Fertility Treatments Market Competitive Landscape And Company Profiles
29. Appendix
Executive Summary
The fertility treatment market consists of sales services and related products that are used in various applications to treat infertile patients. Fertility treatment is a medical procedure intended to increase the chances of conceiving a child.The global fertility treatments market was worth $14870.3 million in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 8.90% and reach $20913.72 million by 2023.
The fertility treatments market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. Asia Pacific was the largest region in 2019.
The fertility treatment market covered in this report is segmented by product into reagents, equipment. It is also segmented by end-user into fertility clinics, hospitals, surgical centers, clinical research institutes.
The growth in the median age of first-time motherhood combined with change in lifestyle increased the difficulty of conceiving, increasing the demand for fertility treatment. The median age of first-time motherhood has increased all over the globe due to late marriages, contraceptive techniques, and increase in number of women who prioritize their careers over starting a family. According to statistics from the National Center for Health Statistics in 2018, the average age for having a first baby in the USA was 26.9 years, an increase from 22.7 years in 1980. In this scenario, a growing number of women are being opting for IVF treatments, which is expected to drive this market.
The high cost and low success rate of In vitro fertilization (IVF) treatment is a major factor that limits the growth of the fertility treatments market. In vitro fertilization is a fertilization process in which an egg is fertilized with sperm outside the body, in vitro. In vitro fertilization (IVF) treatment costs differs in many countries due to the lack of refund policies. Moreover, insurance companies usually do not cover infertility treatments. According to the American society of reproductive medicine, in the USA, the average cost of IVF cycle is $12,400 and the average cost of an IVF cycle using fresh embryos is $8,158 with median cost at $7,500. The rate of success of IVF treatments is only 28% to 35%, which decreases with the increase in woman's age. For example, for women, the success rate is 32.2% under 35 and 1.9% for women aged over 44. Thus, the high cost and low success rate of the IVF treatment restrict the growth of the fertility treatment market.
Development of new techniques to treat infertility using a human’s body is a key trend in the fertility treatments market. INVOcell is an IVF alternative that uses the woman’s body to support fertilization, thus eliminating the cost of a laboratory incubator. The INVOcell device is placed with the eggs and sperm in the vaginal cavity, allowing for the stability of the natural environment, pH, and gas to help in fertilization. INVOcell, which is made in Medford, Massachusetts by INVO Bioscience, costs around $6,800 including medication. Although IVF generated more quality embryos, the birth rates between IVF and INVOcell are similar. According to the journal of assisted reproduction and genetics in 2017, 12 out of 20 women gave birth to 15 babies in IVF including three sets of twins and 11 out of 20 women gave birth to 16 babies in INVOcell group including five sets of twins.
In April 2019, Silverfleet Capital, a European based company specialized in mid-market buyouts acquired Care Fertility for an undisclosed amount. Through this acquisition, Silverfleet Capital builds an extensive healthcare experience and aligns with its strategy of supporting companies with strong underlying dynamics of market growth. Care Fertility, a UK based company, offers a range of fertility treatments with a personalized approach to patient care.
Major players in the market are Apollo Hospitals Enterprise Ltd., Care Fertility Group, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, Progyny Inc., Vitrolife, Carolinas Fertility Institute and OvaScience Inc.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Apollo Hospitals Enterprise Ltd.
- Care Fertility Group
- Genea Limited
- The Johns Hopkins Health System Corp
- Medicover Group
- Monash IVF Group
- Progyny Inc.,
- Vitrolife
- Carolinas Fertility Institute
- OvaScience Inc.
- Xytex Cryo International
- Merck KGaA
- Cook Medical
- CooperSurgical, Inc
- Instituto Bernabeu
- INVO Bioscience
- The Cooper Companies Inc.
- Virtus Health
- CryoChoice, LLC
- Millendo Therapeutics, Inc
- FUJIFILM Irvine Scientific
- LABOTECT GMBH
- Fertility Focus
- Olympus Corporation
- Irvine Scientific sales Company, Inc
- Ferring Pharmaceuticals
Methodology
LOADING...
